Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
08/30/2011 | CA2378893C In vivo induction for enhanced function of isolated hepatocytes |
08/30/2011 | CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines |
08/30/2011 | CA2331329C Diacylglycerol acyl transferase proteins |
08/25/2011 | WO2011102149A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
08/25/2011 | WO2011101602A1 Nanoemulsion for the delivery of at least two agents of interest |
08/25/2011 | WO2011101600A1 Use of a neutralising composition by ingestion to treat or prevent the appearance of aphthas |
08/25/2011 | WO2011101374A1 Compositions comprising amphetamin and lisdexamfetamine |
08/25/2011 | WO2011101340A1 Zeolite-containing preparations containing clinoptilolite and uses thereof |
08/25/2011 | WO2011101113A1 Pharmaceutical comprising myramistin |
08/25/2011 | WO2011100994A1 Pharmaceutical comprising myramistin |
08/25/2011 | WO2011076946A3 Methods and compositions for the treatment of alzheimer |
08/25/2011 | US20110207806 Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
08/25/2011 | US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
08/25/2011 | US20110207658 High Purity Lipopeptides |
08/25/2011 | US20110206755 Methods and products for manipulating uncoupling protein expression |
08/25/2011 | US20110206671 Axon regeneration promoter |
08/25/2011 | US20110206664 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
08/25/2011 | US20110206636 Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus |
08/25/2011 | US20110206635 Uses of il-12 in hematopoiesis |
08/25/2011 | US20110206631 Ion binding polymers and uses thereof |
08/25/2011 | US20110206622 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto |
08/25/2011 | US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
08/25/2011 | US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
08/25/2011 | CA2789665A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
08/24/2011 | EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof |
08/24/2011 | EP2360253A1 RNA sequence-specific mediators of RNA interference |
08/24/2011 | EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs |
08/24/2011 | EP2360185A2 Administration of agents for the treatment of inflammation |
08/24/2011 | EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using |
08/24/2011 | EP2360169A2 PSMA antibodies |
08/24/2011 | EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
08/24/2011 | EP2359852A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound |
08/24/2011 | EP2359849A1 Combination therapy |
08/24/2011 | EP2359847A1 Modulation of beta-amyloid levels by beta-secretase bace2 |
08/24/2011 | EP2359840A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
08/24/2011 | EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines |
08/24/2011 | EP2359829A1 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
08/24/2011 | EP2359826A1 Combination of HMG-COA reductase inhibitors, such as roflumilast, roflumilast-N-oxide with a phosphodiesterase 4 inhibitor, rosuvastatin, for the treatment of inflammatory pulmonary diseases |
08/24/2011 | EP2359688A1 Organ arrest, protection and preservation |
08/24/2011 | EP2358378A2 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof |
08/24/2011 | EP1901775B1 Kinin antagonists for treating bladder dysfunction |
08/24/2011 | EP1572128B1 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
08/24/2011 | EP1531843B1 Method for treating cervical cancer |
08/24/2011 | EP1505990B1 Methods of treating hepatitis |
08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
08/24/2011 | EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
08/24/2011 | EP1259544B1 Heterologous polypeptide of the tnf family |
08/24/2011 | EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
08/24/2011 | EP0754059B2 Methods and compositions useful for inhibition of angiogenesis |
08/24/2011 | CN1775289B Multi vitamin oral disintegrating tablet formulation and its preparing method |
08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
08/24/2011 | CN102164614A Use of an Ang-(1-7) receptor agonist in acute lung injury |
08/24/2011 | CN102164594A Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs |
08/24/2011 | CN102160891A Hcv ns3-ns4a protease inhibition |
08/24/2011 | CN101102776B Antitumor agent |
08/23/2011 | USRE42645 Nutritional or therapeutic compositions and methods to increase bodily glutathione levels |
08/23/2011 | US8003776 Mycobacterial antigens expressed during latency |
08/23/2011 | US8003704 Tryptophan metabolite as aldehyde dehydrogenase inhibitor; side effect reduction |
08/23/2011 | US8003688 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
08/23/2011 | US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
08/23/2011 | US8003630 Comprises therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin (opioid growth factor); cancer |
08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
08/23/2011 | US8003315 TAOJIKs as modifiers of the beta-catenin pathway and methods of use |
08/23/2011 | US8003131 Biomaterial derived from vertebrate liver tissue |
08/23/2011 | US8003115 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
08/23/2011 | US8003101 Inflammatory mediator antagonists |
08/23/2011 | US8003094 Combination with a solvent, skin buffer and antioxidant to improve solubility and bioavailability for a variety of dosage forms |
08/23/2011 | CA2729518A1 Multiplication of the efficacy of anti-infectious agents by a composition comprising an extract made from dehydrated and partially sodium-free seawater |
08/23/2011 | CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy |
08/23/2011 | CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors |
08/23/2011 | CA2488789C Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
08/23/2011 | CA2486078C Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
08/23/2011 | CA2456076C Integrin inhibitors for the treatment of eye diseases |
08/23/2011 | CA2442159C Treatment using neublastin polypeptides |
08/23/2011 | CA2403994C Nasal administration of agents for the treatment of gastroparesis |
08/23/2011 | CA2348926C Methods and compositions for the prevention of tolerance to medications |
08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
08/18/2011 | WO2011100319A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k and mtor in combination with autophagy inhibitors |
08/18/2011 | WO2011100285A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
08/18/2011 | WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
08/18/2011 | WO2011099031A1 Active antioxidants for all age group |
08/18/2011 | WO2011098698A1 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures |
08/18/2011 | WO2011098456A1 Safinamide in the treatment of dyskinesia |
08/18/2011 | WO2011079249A3 Vitamin d glycosides and sulfates for treating diseases |
08/18/2011 | US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same |
08/18/2011 | US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
08/18/2011 | US20110201029 Il-13 receptor antibodies |
08/18/2011 | US20110200593 Combination Therapy for the Treatment of Ocular Neovascular Disorders |
08/18/2011 | US20110200553 Compounds and methods for the treatment or prevention of flavivirus infections |
08/18/2011 | CA2789229A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
08/18/2011 | CA2783303A1 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures |
08/17/2011 | EP2357582A1 Methods and devices for identifying patterns in biological systems |
08/17/2011 | EP2357478A2 Diagnosis of disease |
08/17/2011 | EP2357474A1 Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia |
08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
08/17/2011 | EP2357003A2 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression |
08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |
08/17/2011 | EP2356982A2 Antimicrobial compositions and methods |